Basel Medical Group Ltd (NASDAQ:BMGL) Short Interest Up 157.1% in July

Posted by Brian Himes on Jul 27th, 2026

Basel Medical Group Ltd (NASDAQ:BMGL – Get Free Report) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totaling 32,559 shares, an increase of 157.1% from the June 30th total of 12,662 shares. Based on an average trading volume of 70,687 shares, the days-to-cover ratio is currently 0.5 days. Approximately 2.1% of the company’s shares are short sold.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised Basel Medical Group from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, July 16th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.

Get Our Latest Research Report on Basel Medical Group

Basel Medical Group Price Performance

Basel Medical Group stock traded up $0.11 during midday trading on Monday, hitting $5.90. 5,661 shares of the stock were exchanged, compared to its average volume of 28,979. The company has a fifty day simple moving average of $6.90 and a two-hundred day simple moving average of $7.52. The company has a quick ratio of 1.83, a current ratio of 1.88 and a debt-to-equity ratio of 0.93. Basel Medical Group has a 52 week low of $4.60 and a 52 week high of $27.36.

Basel Medical Group (NASDAQ:BMGL – Get Free Report) last issued its earnings results on Friday, June 26th. The company reported $0.01 EPS for the quarter. The firm had revenue of $3.21 million during the quarter.

Institutional Trading of Basel Medical Group

A number of large investors have recently made changes to their positions in BMGL. Citadel Advisors LLC acquired a new stake in Basel Medical Group during the 3rd quarter worth $169,000. Virtu Financial LLC lifted its holdings in Basel Medical Group by 108.8% during the third quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock worth $61,000 after acquiring an additional 17,608 shares in the last quarter. Finally, Marex Group plc bought a new position in Basel Medical Group during the second quarter worth about $25,000.

About Basel Medical Group

(Get Free Report)

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.